Campbell, Randolph E.,Erickson, Signe,Bueche, Blaine,De Juan Jr., Eugene,Alster, Yair,Chamow, Steven M.,Farinas, Kathleen Cogan,Macfarlane, K. Angela,Reich, Cary J.
申请号：
AU2011329656
公开号：
AU2011329656B2
申请日:
2011.11.18
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
An injectable formulation of therapeutic agent may comprise the therapeutic agent and a stabilizer such that a substantial portion of the stabilizer remains in the therapeutic device to stabilize the therapeutic agent when the therapeutic agent is released from the therapeutic device. The injectable formulation may comprise one or more of binding agent particles or erodible material particles, such that the formulation can be injected into the therapeutic device. The binding agent particles can bind reversibly to the therapeutic agent so as to modulate release of the therapeutic agent, and the erodible material particles can generate protons of an acid so as to increase stability of the therapeutic agent and may modulate release of the therapeutic agent. The therapeutic agent can be combined with one or more of the stabilizer, the binding agent particles or the erodible particles to increase stability of the therapeutic agent and may modulate release.
